Jagaran Chakma

Bangladesh’s pharmaceutical exports rose by 3.46 percent year-on-year in the first ten months of the current fiscal year, despite a sharp drop in April due mainly to holidays in key markets and US aid cuts hurting merchandise shipments. 

The Chief Adviser’s Office has recently formed an eight-member committee to assess the proposed merger of several investment-related agencies under the single umbrella of the Bangladesh Investment Development Authority (Bida).

The Detailed Area Plan (DAP) aims to strike a balance between development and sustainability of Dhaka, according to the Bangladesh Institute of Planners (BIP), as it says relaxing DAP guidelines to favour real estate interests would cause long-term consequences to the liveability of the megacity.

Regulations in the Detailed Area Plan (DAP) are limiting housing responses to meet Dhaka’s growing accommodation needs, according to realtors, as they argue that current urban policies are doing more harm than good.

Just five days after issuing a gazette notification imposing export fees on raw jute and jute products, the government has withdrawn the order to review the decision, following strong concerns from industry stakeholders over what they described as an excessive hike.

Best Holdings Ltd is set to open the first five-star hotel in Bangladesh’s industrial belt by June 2026, introducing luxury hospitality to Bhaluka in Mymensingh district.

Giordano Korea CEO sees ‘familiar signs of promise’ as he plans a factory in economic zone

Bangladesh’s healthcare sector has the potential to reach $23 billion by 2030, positioning the country as a major destination for foreign direct investment (FDI), according to a presentation shared at the Bangladesh Investment Summit.

Foreign direct investment (FDI) from China in Bangladesh has risen to $2.67 billion as of September 2024, according to official data, cementing China’s position as the country’s second-largest investor.

"This downtrend will lead to severe consequences if it is not reversed"

The government has launched an initiative to modernise and revive six shuttered sugar mills, aiming to transform them into profitable enterprises through public-private partnerships and advanced technology.

Bangladesh’s pharmaceutical exports posted steady growth in the first eight months of the current fiscal year, buoyed by rising demand from developed markets, though a sharp decline in February raised concerns, industry experts said.

Shipments go up 21.25% in first eight months of FY25

Bangladesh’s exports have shown resilience, displaying steady growth in key sectors such as garments, plastics and seafood in the first eight months of fiscal year (FY) 2024-25, somewhat defying global economic headwinds and domestic concerns like high inflation and political uncertainty.

The government’s borrowing from domestic sources surged in the first half of FY25, primarily driven by a substantial increase in the issuance of special bonds, particularly those issued to clear arrears to electricity and fertiliser producers, as well as treasury bills (T-bills) and bonds targeting institutional and individual investors.

The industry currently has a market size of around Tk 6,250 crore

Singer Bangladesh has started the commercial production of home appliances at its new plant, becoming the first company to operate in the Bangladesh Special Economic Zone (BSEZ) in Araihazar of Narayanganj.

Bangladesh’s footwear sector is at a turning point, offering lucrative investment opportunities in both the leather and non-leather segments. However, challenges in sustaining growth and enhancing competitiveness remain, the Bangladesh Investment Development Authority (Bida) highlighted in a newsletter released yesterday.

In search of a better future, Md Selim and Hasanuzzaman Hassan migrated to the US roughly over three decades ago. The brothers eventually found success in construction business there but could not ignore the urge for contributing to their homeland. 

Foreign participants at the 16th Asia Pharma Expo foresee a bright future for Bangladesh’s pharmaceutical industry, given its continuous product development and expanding global footprint.